Issue date: February 2011.
"This guidance was developed using the single technology appraisal process."
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.